Literature DB >> 19504756

Trypanosoma cruzi maxicircle heterogeneity in Chagas disease patients from Brazil.

Julio César Carranza1, Helder M S Valadares, Daniella A D'Avila, Rodrigo P Baptista, Margoth Moreno, Lúcia M C Galvão, Egler Chiari, Nancy R Sturm, Eliane D Gontijo, Andrea M Macedo, Bianca Zingales.   

Abstract

The majority of individuals in the chronic phase of Chagas disease are asymptomatic (indeterminate form, IF). Each year, approximately 3% of them develop lesions in the heart or gastrointestinal tract. Cardiomyopathy (CCHD) is the most severe manifestation of Chagas disease. The factors that determine the outcome of the infection are unknown, but certainly depend on complex interactions amongst the genetic make-up of the parasite, the host immunogenetic background and environment. In a previous study we verified that the maxicircle gene NADH dehydrogenase (mitochondrial complex I) subunit 7 (ND7) from IF isolates had a 455 bp deletion compared with the wild type (WT) ND7 gene from CCHD strains. We proposed that ND7 could constitute a valuable target for PCR assays in the differential diagnosis of the infective strain. In the present study we evaluated this hypothesis by examination of ND7 structure in parasites from 75 patients with defined pathologies, from Southeast Brazil. We also analysed the structure of additional mitochondrial genes (ND4/CR4, COIII and COII) since the maxicircle is used for clustering Trypanosoma cruzi strains into three clades/haplogroups. We conclude that maxicircle genes do not discriminate parasite populations which induce IF or CCHD forms. Interestingly, the great majority of the analysed isolates belong to T. cruzi II (discrete typing unit, (DTU) IIb) genotype. This scenario is at variance with the prevalence of hybrid (DTU IId) human isolates in Bolivia, Chile and Argentina. The distribution of WT and deleted ND7 and ND4 genes in T. cruzi strains suggests that mutations in the two genes occurred in different ancestrals in the T. cruzi II cluster, allowing the identification of at least three mitochondrial sub-lineages within this group. The observation that T. cruzi strains accumulate mutations in several genes coding for complex I subunits favours the hypothesis that complex I may have a limited activity in this parasite.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504756     DOI: 10.1016/j.ijpara.2009.01.009

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  14 in total

Review 1.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 2.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

3.  The centennial of the discovery of Chagas disease: facing the current challenges.

Authors:  Joseli Lannes-Vieira; Tania C de Araújo-Jorge; Maria de Nazaré Correia Soeiro; Paulo Gadelha; Rodrigo Corrêa-Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

4.  Mitochondrial bioenergetics and redox state are unaltered in Trypanosoma cruzi isolates with compromised mitochondrial complex I subunit genes.

Authors:  Julio César Carranza; Alicia J Kowaltowski; Marco Aurélio G Mendonça; Thays C de Oliveira; Fernanda R Gadelha; Bianca Zingales
Journal:  J Bioenerg Biomembr       Date:  2009-07-18       Impact factor: 2.945

5.  Genotyping of Trypanosoma cruzi sublineage in human samples from a North-East Argentina area by hybridization with DNA probes and specific polymerase chain reaction (PCR).

Authors:  Cristina Diez; Virginia Lorenz; Silvia Ortiz; Verónica Gonzalez; Andrea Racca; Iván Bontempi; Silvia Manattini; Aldo Solari; Iván Marcipar
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

6.  Enigmatic presence of mitochondrial complex I in Trypanosoma brucei bloodstream forms.

Authors:  Sachin Surve; Meredith Heestand; Brian Panicucci; Achim Schnaufer; Marilyn Parsons
Journal:  Eukaryot Cell       Date:  2011-12-09

7.  Multiple mitochondrial introgression events and heteroplasmy in trypanosoma cruzi revealed by maxicircle MLST and next generation sequencing.

Authors:  Louisa A Messenger; Martin S Llewellyn; Tapan Bhattacharyya; Oscar Franzén; Michael D Lewis; Juan David Ramírez; Hernan J Carrasco; Björn Andersson; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2012-04-10

8.  Chagas cardiomyopathy manifestations and Trypanosoma cruzi genotypes circulating in chronic Chagasic patients.

Authors:  Juan David Ramírez; Felipe Guhl; Lina María Rendón; Fernando Rosas; Jose A Marin-Neto; Carlos A Morillo
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

9.  The Trypanosoma cruzi Sylvio X10 strain maxicircle sequence: the third musketeer.

Authors:  Laura I Ruvalcaba-Trejo; Nancy R Sturm
Journal:  BMC Genomics       Date:  2011-01-24       Impact factor: 3.969

10.  Unequivocal identification of subpopulations in putative multiclonal Trypanosoma cruzi strains by FACs single cell sorting and genotyping.

Authors:  Helder Magno Silva Valadares; Juliana Ramos Pimenta; Marcela Segatto; Vanja Maria Veloso; Mônica Lúcia Gomes; Egler Chiari; Kenneth John Gollob; Maria Terezinha Bahia; Marta de Lana; Glória Regina Franco; Carlos Renato Machado; Sérgio Danilo Junho Pena; Andréa Mara Macedo
Journal:  PLoS Negl Trop Dis       Date:  2012-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.